VDPHL01 Oral Minoxidil Achieves Phase 3 Trial Goals
Veradermics reported positive Phase 3 trial results for its oral hair growth drug, VDPHL01, potentially becoming the first FDA-approved non-hormonal pill for male pattern baldness.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed